鼻型结外NK／T细胞淋巴瘤治疗的研究进展

Treatment progress of extranodal natural killer/T-cell lymphoma, nasal type

结外NK/T细胞淋巴瘤,鼻型（ENKTL）是一种侵袭性非霍奇金淋巴瘤.ENKTL目前尚无标准治疗方案,局限期患者可考虑单纯放疗或放化疗联合治疗,多药联合化疗为晚期患者主要治疗手段,以蒽环类药物为主的传统化疗方案对ENKTL的疗效欠佳.近年,一些新的治疗方案在ENKTL中显示出一定的疗效,文章就ENKTL治疗的进展进行综述.

Extranodal natural killer （NK）/T-cell lymphoma, nasal type （ENKTL） is an aggressive non-Hodgkin lymphoma and there are no standard treatment options for ENKTL. For localized patients, radiotherapy alone or radiotherapy combined with chemotherapy could be took into consideration. Systemic combination chemotherapy remains the primary treatment for patients with advanced ENKTL. The efficacy of anthracycline based conventional chemotherapy in ENKTL is unfavorable. This paper reviews the treatment progress of ENKTL in recent years.